India prednisolone market is expected to grow at a steady rate during the forecast period. The India prednisolone market is driven by high use of this medication to treat a number of inflammatory and autoimmune conditions such as asthma, uveitis, pyoderma gangrenosum, rheumatoid arthritis, among others. Additionally, the drug is also used as an immunosuppressive drug for organ transplants which is further expected to boost the demand through FY2026. Improvement in healthcare infrastructure is further predicted to bolster the market growth in the years to come.

The India prednisolone market is segmented based on form, route of administration, distribution channel, source, application, end user, company, and region. Based on form, the market is segmented into capsule, tablet, injection, syrup, eye drops. Among them, the tablet segment dominated the market until 2019 and is further projected to maintain its dominance in the market during the forecast years as well on account of their longer shelf life than other alternatives present in the market. Also, the capsule segment is anticipated to grow at a high CAGR in the market over the next five years because capsules are fast-acting and often more powerful than tablet because it only takes few minutes for a liquid filled capsule to be broken down and get absorbed into the bloodstream.

The major players operating in the India prednisolone market are Cipla Ltd., Avik Pharmaceutical Limited, Anuh Pharma Ltd., Neon Laboratories Limited, Psychotropics India Limited, Nicholas Piramal India Ltd., Mankind Pharma Pvt. Ltd., Macleods Pharmaceuticals Ltd., Allergan India Pvt. Ltd., Sanofi Aventis Pharma India Ltd., and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies, and launching new products in order to stay competitive in the market. Other inorganic growth strategies include mergers & acquisitions, joint ventures, and new product developments in order to sustain themselves amidst fierce competition.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India Prednisolone market from FY2016 to FY2019.
  • To estimate and forecast the market size of India prednisolone market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India prednisolone market based on form, route of administration, distribution channel, source, application, end user, company, and regional distribution.
  • To identify dominant region or segment in the India prednisolone market.
  • To identify drivers and challenges for India prednisolone market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India prednisolone market.
  • To identify and analyze the profile of leading players operating in India prednisolone market.
  • To identify key sustainable strategies adopted by market players in India prednisolone market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India prednisolone market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Prednisolone manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to prednisolone

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India prednisolone market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Prednisolone Market, By Form:
    • Tablet
    • Capsule
    • Injection
    • Syrup
    • Eye Drops
  • India Prednisolone Market, By Route of Administration:
    • Oral
    • Intravenous
    • Ophthalmic
  • India Prednisolone Market, By Distribution Channel:
    • Online
    • Offline
  • India Prednisolone Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Prednisolone Market, By Application:
    • Inflammation
    • Rheumatoid Arthritis
    • Acute Lymphoblastic Leukaemia
    • Autoimmune Hepatitis
    • Others
  • India Prednisolone Market, By End User:
    • Adult
    • Pediatric
  • India Prednisolone Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India prednisolone market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India prednisolone market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Prednisolone Market

4.    Executive Summary

5.    Manufacturing Prednisolone

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Prednisolone

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Prednisolone Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Form (Capsule, Tablet, Injection, Syrup, Eye Drops)

7.2.2.     By Route of Administration (Oral, Ophthalmic, Intravenous)

7.2.3.     By Distribution Channel (Online v/s Offline)

7.2.4.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.5.     By Application (Inflammation, Rheumatoid Arthritis, Acute Lymphoblastic Leukaemia, Autoimmune Hepatitis, and Others)

7.2.6.     By End User (Adult v/s Pediatric)

7.2.7.     By Region (North, East, South, West)

7.2.8.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Cipla Ltd.

14.1.1.1.      Company Brief

14.1.1.2.      Production Plants & Capacity (If Available)

14.1.1.3.      Financials (If Available)

14.1.1.4.      Captive Consumption Vs Merchant Sale

14.1.1.5.      Current & Future Plans

14.1.2.  Avik Pharmaceutical Limited

14.1.3.  Anuh Pharma Ltd.

14.1.4.  Neon Laboratories Limited

14.1.5.  Psychotropics India Limited

14.1.6.  Nicholas Piramal India Ltd.

14.1.7.  Mankind Pharma Pvt. Ltd.

14.1.8.  Macleods Pharmaceuticals Ltd.

14.1.9.  Allergan India Pvt. Ltd.

14.1.10.                Sanofi Aventis Pharma India Ltd.

15.  Strategic Recommendations

16. About Us & Disclaimer 

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com